Literature DB >> 32517788

Correction to: Relevance of biomarkers across different neurodegenerative diseases.

Alexander J Ehrenberg1,2,3, Ayesha Khatun4, Emma Coomans5, Matthew J Betts6,7, Federica Capraro8,9, Elisabeth H Thijssen10,11, Konstantin Senkevich12,13, Tehmina Bharucha14, Mehrsa Jafarpour15, Peter N E Young16,17, William Jagust18,19, Stephen F Carter20,21, Tammaryn Lashley15,22, Lea T Grinberg10,23,24, Joana B Pereira25,26, Niklas Mattsson-Carlgren16,17, Nicholas J Ashton16,17,27,28, Jörg Hanrieder15,16, Henrik Zetterberg15,16,29,30, Michael Schöll15,16,26, Ross W Paterson4.   

Abstract

An amendment to this paper has been published and can be accessed via the original article.

Entities:  

Year:  2020        PMID： 32517788      PMCID： PMC7285493          DOI： 10.1186/s13195-020-00637-y

Source DB:  PubMed          Journal:  Alzheimers Res Ther            Impact factor:   6.982


Correction to: Alz Res Ther 12, 56 (2020) https://doi.org/10.1186/s13195-020-00601-w Following publication of the original article [1], the authors reported a production error in the article title. The last word "diseases" was omitted by copy editor. The original article [1] has been updated.
  1 in total

Review 1.  Relevance of biomarkers across different neurodegenerative diseases.

Authors:  Alexander J Ehrenberg; Ayesha Khatun; Emma Coomans; Matthew J Betts; Federica Capraro; Elisabeth H Thijssen; Konstantin Senkevich; Tehmina Bharucha; Mehrsa Jafarpour; Peter N E Young; William Jagust; Stephen F Carter; Tammaryn Lashley; Lea T Grinberg; Joana B Pereira; Niklas Mattsson-Carlgren; Nicholas J Ashton; Jörg Hanrieder; Henrik Zetterberg; Michael Schöll; Ross W Paterson
Journal:  Alzheimers Res Ther       Date:  2020-05-13       Impact factor: 6.982
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.